Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems. Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019. Read more details @ http://www.bigmarketresearch.com/global-infertility-2015-2019-market
All updated as on - With an initial valuation of $3.22B in 2023, the global infertility treatment market is expected to reach $5.16B by 2031, expanding from $3.59B in 2024 at a CAGR of 8.1%.
The Global Infertility Treatment Devices Industry 2015 report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.
This report provides top line data relating to the clinical trials on Male Infertility. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe... To know more, click on the link below: https://www.kenresearch.com/healthcare/pharmaceuticals/male-infertility-global-clinical-trials-review/142673-91.html
Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems. Get full access of the report @: http://www.researchbeam.com/global-infertility-2015-2019-market
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
Adroit Market Research recently added a report on the Infertility Treatment Market that has a brief analysis of the market size, sales forecast, and regional landscape of this industry. The report also highlights the key challenges and current growth strategies pursued by leading companies that are part of the dynamic competitive spectrum of this business area.
The global male infertility market is growing at a 4.53% CAGR and is expected to reach $6458.51 million during the forecast period of 2023 to 2032. Read More.
The Global Infertility Services Market is projected to grow from USD xx billion in 2020 to USD xx billion by 2026 at a CAGR of over 8.5% during the forecast period.
The global male infertility market is growing at a 4.53% CAGR and is expected to reach $6458.51 million during the forecast period of 2023 to 2032. Read More: https://inkwoodresearch.com/male-infertility-market-insights/
Data Bridge Market Research analyses that the infertility testing market to account USD 722.59 by 2028 and growing at a CAGR of 6.75% in the forecast period of 2021-2028. https://www.databridgemarketresearch.com/reports/global-infertility-testing-market
Stay up-to-date with latest Insights of IVF Services market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
The major players in the in vitro fertilization market include CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US).
Fertility services are defined as services that can help both men and women to overcome medical problems, which prevent them from having children. A new report on the global Fertilizer Service Company published by Market Research Future (MRFR), observes that this market could find growth at 6.50% CAGR between 2020 and 2027. The prominent market enhancing factors for the global fertility services market include growing urbanization, rising numbers of women joining the workforce, the inclination of women for advanced studies, delayed family planning, and reimbursement schemes. Another crucial fa
Uterine polyps is also known as endometrial polyps which is characterized by the abnormal growth of the tissues from the inner lining of the endometrium (uterus) which further leads to the formation of small bean like structure known as polyps. These polyps are generally benign (non-cancerous) but eventually can change into cancerous and turn into malignant from of cancer (precancerous polyps).
Rise in incidence of infertility-related problems in both the genders drive the growth of the global hCG market. In addition, upsurge in the adoption of hCG hormone in pain management and weight loss propel the market growth.
In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. See Full Report @ bit.ly/1oDB8r0
Fertility supplements are the supplements that are consumed by individuals to improve their fertility rate. In other words, it is a kind of natural process that helps individuals in reproducing their off-springs.
The major challenge in Asia-Pacific IVF devices market is affordability of these devices by the small sized IVF clinics. Asia-Pacific IVF devices and consumables market accounted for about 469.6 million in 2014 and is expected to grow at a CAGR of 21.7% from 2015 to 2020. To know more visit us @ http://www.apacmarket.com/top-market/apac-ivf-devices-and-consumables-market
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. See Full Report @ http://bit.ly/1zVmJyK
The global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. See Full Report : http://bit.ly/1KPbjj6
The global endocrine testing market was valued at US$6 billion in 2014 and is estimated to reach near about US$13 bn by 2023 at a CAGR of 8.8% from 2015 to 2023.
According to the latest research report by IMARC Group, The global male infertility market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.79% during 2024-2032. More Info:- https://www.imarcgroup.com/male-infertility-market
The growing incidences of infertility and miscarriages, particularly among the modern couples, are primarily driving the adoption of infertility drugs. In line with this, the rising consumer awareness towards several benefits of infertility drugs in enhancing the chances of pregnancy in couples is also augmenting the market growth on a global level Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/infertility-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Male Infertility Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others); Treatment Type (Assisted Reproductive Technology, Varicocele Surgery, Medication); Distribution Channel (Hospitals Pharmacies, Pharmacies and Drug Stores, Online Pharmacies); End User (Hospitals and Clinics, Fertility Centers, Research Institutes, Other End Users), and Geography
Global fertility services market size is expected to reach $101.76 Bn by 2028 at a rate of 13.2%, segmented as by type, milk and butter, cheese, dry, condensed, and evaporated dairy products, ice cream and frozen dessert
The global urinary incontinence market size was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030.
Data Bridge Market Research analyses that the infertility treatment market is expected to undergo a CAGR of 8.03% during the forecast period. This indicates that the market value, which was USD 1.50 billion in 2021, would rocket up to USD 2.78 billion by 2029. “Assisted Reproductive Technology (ART)” dominates the application segment of the infertility treatment market owing to the increasing number of technological advancements, growing awareness about assisted reproductive technology (ART) and increase in funding for research and development into microbiome-based therapies worldwide. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
The South Korea male infertility market is expected to progress with an 8.25% CAGR between the forecasting years 2023 and 2030. Request a Free Sample Report.
Infertility Treatment Devices and Equipment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Ovum Aspiration Pumps, Sperm Separation Devices, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Others); Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery); End User (Fertility Clinics, Hospitals and Other Healthcare Facilities, and Clinical Research Institutes), and Geography
The global male infertility market is growing at a 4.53% CAGR and is expected to reach $6458.51 million during the forecast period of 2023 to 2032. Read More
The Business Research Company offers female fertility and pregnancy rapid test market research report 2023 with industry size, share, segments and market growth
The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
Ubiquinone Market is moderately consolidated with the presence of few companies in the industry holding significant share. Some of the key players for ubiquinone market are Kaneka Corporation, Captek, MGC Pharmaceuticals, Xiamen Kingdonway, Pharma Essentia
The global family planning centers market was valued at $4.4 billion in 2017. Request sample: https://www.thebusinessresearchcompany.com/sample.aspx?id=541&type=smp
Fertility drugs refer to a term used to describe medications that cause your body to release hormones that regulate or prompt ovulation, or the release of an egg from your ovary.
IVF Services Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Cycle Type (Fresh IVF Cycles, Thawed IVF Cycles, and Donor Egg IVF Cycles); End User (Fertility Clinics, Hospitals, and Surgical Centers and Clinical Research Institutes), and Geography
UK IVF services market is estimated to reach $685.4 million by 2022, registering a CAGR of 7.7% from 2016 to 2022. The UK IVF services market is characterized by important factors such as increase in cases of infertility, delayed marriages, and parenthood decisions. In addition, decrease in birthrate also boost the market growth. For instance, in 2014 total fertility rate decreased to 1.83 per woman from 1.85 in 2013.
Bharat Book Bureau provides the report, on “ Industry Report on Fertility Market in US [2016 -2020] ”. https://www.bharatbook.com/healthcare-market-research-reports-750007/fertility-us.html In males, low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm can lead to infertility.
The global biosimilar market size reached US$ 21.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 164.5 Billion by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032.
Big Market Research, Women Infertility Global Clinical Trials Review, H2, Research Report Size, Analysis, Share, Research, Industry, Growth, Trends, Report, Opportunities and Forecast,2014 GlobalData's clinical trial report, “Women Infertility Global Clinical Trials Review, H2, 2014" provides data on the Women Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Women Infertility.
According to #TechSci Research report, India Hospital Market stood at USD66.77 billion in FY2021 and is expected to grow at a steady CAGR of 8.32% during the forecast period. Gain more Insight: https://bit.ly/3z6Ew9Q Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
According to our new market research study on “Male Infertility Market – Global Analysis and Forecast – by Test, Treatment Type, Distribution Channel, and End-User,” the market is expected to reach US$ 6,213.96 million by 2027 from US$ 3,883.82 million in 2019; it is estimated to grow at a CAGR of 6.2% from 2020 to 2027. The report highlights the trends prevailing in the global male infertility market, and the drivers and deterrents pertaining to its growth. The growth of the male infertility market is attributed to the increase in male infertility worldwide and technological advancements. However, high cost of procedures hampers the growth of the market.
Download Sample Brochure @ http://tinyurl.com/z7qffhr ‘Women Infertility - Pipeline Review, H2 2015’, provides an overview of the Women Infertility’s therapeutic pipeline. Scope - The report provides a snapshot of the global therapeutic landscape of Women Infertility - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Women Infertility and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Women Infertility products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Infertility testing is a series of tests which is used to determine why a woman is unable to conceive. The tests also aids in determining whether the issue is with the man, woman, or both. Infertility testing and evaluation are costly and the treatment might be a little uncomfortable at times. Sperm penetration assay,
INFERTILITY TESTING AND TREATMENT market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global INFERTILITY TESTING AND TREATMENT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.